A5063264010- Research on Leishmaniasis Studies
- Organ Transplantation Techniques and Outcomes
- Chronic Lymphocytic Leukemia Research
- Healthcare Systems and Public Health
- Systemic Sclerosis and Related Diseases
- Fungal Infections and Studies
- Pancreatic and Hepatic Oncology Research
- Microscopic Colitis
- Renal Transplantation Outcomes and Treatments
- Celiac Disease Research and Management
- Diabetes Management and Research
- Inflammatory Bowel Disease
- Nursing care and research
- Immunodeficiency and Autoimmune Disorders
- Diagnosis and Treatment of Venous Diseases
Hospital General Universitari de Castelló
2023-2025
North Atlantic Treaty Organization
2018
ABSTRACT Background Leishmaniasis (LI) is a vector‐borne illness caused by protozoan of the genus Leishmania . Data on features LI in patients with inflammatory bowel disease (IBD) are scarce. Aim To describe characteristics IBD who present leishmaniasis, infection outcomes and risk factors associated developing visceral leishmaniasis (VL). Methods An observational retrospective study performed 26 hospitals Spain, including all adult developed from 2012 to 2022. Results A total 73 were...
Abstract Background Chronic refractory pouchitis (RP) is a complication of ileal pouch-anal anastomosis (IPAA). Vedolizumab (VDZ) has been used in RP management, but real-world data on its effectiveness are limited. Additionally, information switching from intravenous (IV) to subcutaneous (SC) VDZ this context scarce. Aims To evaluate the efficacy and safety treatment clinical setting, assess outcomes following transition IV SC VDZ, compare persistence between administration. Methods A...
Summary Background Ustekinumab is approved for ulcerative colitis (UC). Aims To assess the durability of ustekinumab in patients with UC and its short‐term effectiveness, tolerability clinical practice. Methods Retrospective, multicentre study who had received their first dose at least 16 weeks before inclusion. Patients were followed until treatment discontinuation or last visit. Only active disease start considered effectiveness analysis. stopped visit not to be subsequent remission....
La Diabetes es una enfermedad crónica y prevalente, que tiene un desarrollo gradual para cuyo control son esenciales el consejo la guía del personal sanitario, junto con atención paciente.Por lo tanto, resulta imprescindible paciente conozca entienda su patología las opciones tratamiento, cómo afecta a calidad de vida, así como pueda valorar sus propias preferencias sepa dónde ha buscar información.Se elaborado herramienta ayuda objetivo proporcionar información sobre diferentes manera...